UpdatesGeneral Updates

Rubicon Research's Pithampur facility received 2 procedural observations from a US FDA inspection.

Rubicon Research LimitedRUBICON · Filed with the exchange

The company is confident in timely resolution and plans to ramp up operations from next year.

Read the original filing(PDF)

No comments yet. Be the first.

More from Rubicon Research Limited

All announcements